Home LiteratureArticle Details
PMID: 8428976 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms.

The Journal of biological chemistry ·Vol. 268 ·No. 5 ·1993-02-15 ·Pages 3021-4

Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ

Abstract

We have analyzed the cellular processing pathways which produce the 4-kDa amyloid beta-peptide (A beta) and a 3-kDa derivative (p3) of the beta-amyloid precursor protein (beta APP) found in conditioned media of tissue culture cells and in cerebrospinal fluid. Pulse-chase experiments reveal that both peptides are secreted in parallel with soluble beta APP (APPs); no precursor-product relation between A beta and p3 was found. The protease inhibitor leupeptin did not influence the production of either peptide. In contrast, the weak base ammonium chloride (NH4Cl) showed a dose-dependent inhibition of A beta production with less decrease in p3. A similar effect was observed using the monovalent ionophore monensin. Brefeldin A completely inhibited the generation of both peptides, indicating that proteases located in the endoplasmic reticulum or early Golgi are not sufficient for the production of the small peptides. Deletion of the beta APP cytoplasmic domain, which removes a consensus sequence that probably mediates reinternalization, caused an increase in secretion of both APPs and p3 and did not abolish A beta production. These observations suggest that completely mature beta APP within the late Golgi and/or at the cell surface is a prerequisite for A beta production but processing within the lysosome might not be directly required. p3 appears to derive from the 10-kDa C-terminal stub of beta APP following secretion of APPs.

MeSH Terms
Ammonium Chloride/pharmacology Amyloid beta-Peptides/biosynthesis Amyloid beta-Protein Precursor/biosynthesis,genetics,metabolism Anti-Bacterial Agents/pharmacology Base Sequence Brefeldin A Cell Line Cell Membrane/drug effects,metabolism Codon/genetics Colchicine/pharmacology Cyclopentanes/pharmacology Golgi Apparatus/drug effects,metabolism Humans Kidney Kinetics Leupeptins/pharmacology Molecular Sequence Data Molecular Weight Monensin/pharmacology Oligodeoxyribonucleotides Peptide Fragments/biosynthesis Sequence Deletion Transfection
Chemicals
Amyloid beta-Peptides Amyloid beta-Protein Precursor Anti-Bacterial Agents Codon Cyclopentanes Leupeptins Oligodeoxyribonucleotides Peptide Fragments Ammonium Chloride Brefeldin A Monensin leupeptin Colchicine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Haass C
Department of Neurology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Hung A Y
Schlossmacher M G
Teplow D B
Selkoe D J
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
1993-02-15
Pages
3021-4
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NIA NIH HHS · AG 06173 · United States
NIA NIH HHS · AG 07911 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com